Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 105310-75-6 | MDL No. : | MFCD11111825 |
Formula : | C23H24N2O3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | JOTWZGIFEGRKFM-HXOBKFHXSA-N |
M.W : | 376.45 | Pubchem ID : | 13718685 |
Synonyms : |
|
Num. heavy atoms : | 28 |
Num. arom. heavy atoms : | 12 |
Fraction Csp3 : | 0.35 |
Num. rotatable bonds : | 7 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 110.53 |
TPSA : | 57.69 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | Yes |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | Yes |
Log Kp (skin permeation) : | -6.49 cm/s |
Log Po/w (iLOGP) : | 3.41 |
Log Po/w (XLOGP3) : | 2.97 |
Log Po/w (WLOGP) : | 2.73 |
Log Po/w (MLOGP) : | 3.08 |
Log Po/w (SILICOS-IT) : | 3.75 |
Consensus Log Po/w : | 3.19 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.9 |
Solubility : | 0.0474 mg/ml ; 0.000126 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.84 |
Solubility : | 0.0538 mg/ml ; 0.000143 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -6.38 |
Solubility : | 0.000156 mg/ml ; 0.000000415 mol/l |
Class : | Poorly soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 3.31 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 209808-47-9 ]
N,N-Diethyl-4-(phenyl(piperidin-4-ylidene)methyl)benzamide hydrochloride
Similarity: 0.80
[ 5274-99-7 ]
1-Benzoylpiperidine-4-carboxylic acid
Similarity: 0.77
[ 1334536-88-7 ]
7-Benzyl-1-oxo-2,7-diazaspiro[3.5]nonane
Similarity: 0.76
[ 2044705-27-1 ]
4-Phenyl-2,8-diazaspiro[4.5]decan-3-one hydrochloride
Similarity: 0.76
[ 423116-18-1 ]
2-(4-Oxocyclohexylmethyl)isoindole-1,3-dione
Similarity: 0.86
[ 6729-50-6 ]
2,3,4,5-Tetrahydro-1H-benzo[c]azepin-1-one
Similarity: 0.80
[ 209808-47-9 ]
N,N-Diethyl-4-(phenyl(piperidin-4-ylidene)methyl)benzamide hydrochloride
Similarity: 0.80
[ 209808-47-9 ]
N,N-Diethyl-4-(phenyl(piperidin-4-ylidene)methyl)benzamide hydrochloride
Similarity: 0.80
[ 30250-67-0 ]
2-(2-Aminoethyl)isoindoline-1,3-dione hydrochloride
Similarity: 0.76
[ 333795-11-2 ]
4-(Piperidin-4-ylmethyl)benzamide hydrochloride
Similarity: 0.74
[ 423116-18-1 ]
2-(4-Oxocyclohexylmethyl)isoindole-1,3-dione
Similarity: 0.86
[ 2436-29-5 ]
3-(1,3-Dioxoisoindolin-2-yl)propanal
Similarity: 0.79